MICALL2, MLXIPL, and MXD3 Link Serum Uric Acid to Immune Evasion and Drug Sensitivity in Prostate Cancer
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
MICALL2, MLXIPL, and MXD3 may promote PCa progression through metabolic–immune crosstalk and serve as potential prognostic biomarkers and predictors of therapeutic response, offering novel insights for precision treatment strategies.
创建时间：
2025-09-03
